Atorib 10

Atorib 10 Tablet is a fixed-dose combination of Atorvastatin, a potent statin, and Clopidogrel, an antiplatelet agent, designed to provide dual protection for cardiovascular health. Atorvastatin works by inhibiting HMG-CoA reductase, the enzyme responsible for cholesterol synthesis, thereby lowering LDL cholesterol, total cholesterol, and triglycerides while modestly increasing HDL cholesterol. This helps prevent plaque buildup in arteries and slows the progression of atherosclerosis. Clopidogrel is a platelet aggregation inhibitor that works by irreversibly blocking the P2Y12 ADP receptor on platelets, reducing the risk of clot formation. The combination of lipid-lowering and antiplatelet action in Atorib 10 makes it an ideal choice for secondary prevention of cardiovascular events. It is commonly prescribed to patients with a history of myocardial infarction, ischemic stroke, peripheral artery disease, or following angioplasty/stent placement to reduce the risk of future heart attacks and strokes.

Common side effects include headache, dizziness, mild gastrointestinal disturbances (such as nausea or diarrhea), and muscle pain. Clopidogrel may increase the risk of bleeding or bruising. Rare but serious side effects include severe muscle injury (rhabdomyolysis), allergic reactions, and gastrointestinal bleeding. Patients should report any unusual bleeding, black/tarry stools, or unexplained muscle pain or weakness to their physician immediately.

Atorib 10 Tablet is indicated for the prevention of cardiovascular events such as heart attack and stroke in patients with established atherosclerotic cardiovascular disease or multiple risk factors. It is particularly used in patients requiring both cholesterol management and antiplatelet therapy after angioplasty or stent placement.

Atorib 10 should be taken only under strict medical supervision. It is contraindicated in patients with active liver disease, bleeding disorders, peptic ulcers, or known hypersensitivity to either component. It is not recommended during pregnancy or breastfeeding due to potential risks to the fetus or infant. Caution should be used in patients undergoing surgery or those taking other anticoagulant or antiplatelet medications, as this combination increases bleeding risk. Alcohol intake should be limited as it can enhance liver-related side effects of Atorvastatin. Regular lipid profile and liver function monitoring are recommended during therapy to ensure safety and effectiveness. Patients should avoid abrupt discontinuation unless advised by their physician, as it may increase the risk of cardiovascular events.

Store Atorib 10 Tablet in a cool, dry place below 30°C. Protect from moisture and direct sunlight. Keep the medication in its original packaging and out of reach of children. Do not use after the expiry date printed on the pack.